BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Camilleri M. Management Options for Irritable Bowel Syndrome. Mayo Clin Proc. 2018;93:1858-1872. [PMID: 30522596 DOI: 10.1016/j.mayocp.2018.04.032] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen LJ, Kamp K, Fang A, Heitkemper MM. Delivery Methods of Cognitive Behavior Therapy for Patients With Irritable Bowel Syndrome. Gastroenterol Nurs 2022. [PMID: 35561102 DOI: 10.1097/SGA.0000000000000671] [Reference Citation Analysis]
2 Ma Y, Qin G, Guo X, Hao N, Shi Y, Li H, Zhao X, Li J, Zhang C, Zhang Y. Activation of δ-opioid receptors in anterior cingulate cortex alleviates affective pain in rats. Neuroscience 2022. [DOI: 10.1016/j.neuroscience.2022.05.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pagán-Busigó JE, López-Carrasquillo J, Appleyard CB, Torres-Reverón A. Beyond depression and anxiety; a systematic review about the role of corticotropin-releasing hormone antagonists in diseases of the pelvic and abdominal organs. PLoS One 2022;17:e0264909. [PMID: 35275963 DOI: 10.1371/journal.pone.0264909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Qin D, Tao QF, Huang SL, Chen M, Zheng H. Eluxadoline Versus Antispasmodics in the Treatment of Irritable Bowel Syndrome: An Adjusted Indirect Treatment Comparison Meta-analysis. Front Pharmacol 2022;13:757969. [PMID: 35281934 DOI: 10.3389/fphar.2022.757969] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shen J, Zhang B, Chen J, Cheng J, Wang J, Zheng X, Lan Y, Zhang X. SAHA Alleviates Diarrhea-Predominant Irritable Bowel Syndrome Through Regulation of the p-STAT3/SERT/5-HT Signaling Pathway. JIR 2022;Volume 15:1745-56. [DOI: 10.2147/jir.s331303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Dai Y, Weng H, Wang Q, Guo X, Wu Q, Zhou L, Huang L. Moxibustion for diarrhea-predominant irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Clinical Practice 2022. [DOI: 10.1016/j.ctcp.2021.101532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Layer P, Andresen V, Allescher H, Bischoff SC, Claßen M, Elsenbruch S, Freitag M, Frieling T, Gebhard M, Goebel-Stengel M, Häuser W, Holtmann G, Keller J, Kreis ME, Kruis W, Langhorst J, Jansen PL, Madisch A, Mönnikes H, Müller-Lissner S, Niesler B, Pehl C, Pohl D, Raithel M, Röhrig-Herzog G, Schemann M, Schmiedel S, Schwille-Kiuntke J, Storr M, Preiß JC, Andus T, Buderus S, Ehlert U, Engel M, Enninger A, Fischbach W, Gillessen A, Gschossmann J, Gundling F, Haag S, Helwig U, Hollerbach S, Karaus M, Katschinski M, Krammer H, Kuhlbusch-Zicklam R, Matthes H, Menge D, Miehlke S, Posovszky MC, Schaefert R, Schmidt-Choudhury A, Schwandner O, Schweinlin A, Seidl H, Stengel A, Tesarz J, van der Voort I, Voderholzer W, von Boyen G, von Schönfeld J, Wedel T; Collaborators:., in Zusammenarbeit mit:., Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM)., Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)., Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)., Deutsche Gesellschaft für Ernährungsmedizin (DGEM)., Deutsche Gesellschaft für Geriatrie (DGG)., Deutsche Gesellschaft für Innere Medizin (DGIM)., Deutsche Gesellschaft für Naturheilkunde (DGNHK)., Deutsche Gesellschaft für Pathologie und Bundesverband deutscher Pathologen e. V. (DGP/BDP)., Deutsche Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM)., Deutsche Gesellschaft für Verhaltensmedizin und Verhaltensmodifikation (DGVM)., Deutsche Schmerzgesellschaft e. V., Deutsches Kollegium für Psychosomatische Medizin (DKPM), Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG)., Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE)., Deutschen Gesellschaft für Kinder- und Jugendmedizin (DGKJ)., Swiss Society of Neurogastroenterology and Motility (SwissNGM)., Informationsforum für Patient:innen mit Magen-Darm-Erkrankungen (MAGDA). Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Z Gastroenterol 2021;59:1323-415. [PMID: 34891206 DOI: 10.1055/a-1591-4794] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Su J, He Z, Yu Y, Lu M, Wu Z, Zhang D. Gualou Xiebai Decoction ameliorates increased Caco-2 monolayer permeability induced by bile acids via tight junction regulation, oxidative stress suppression and apoptosis reduction. J Bioenerg Biomembr 2021. [PMID: 34718922 DOI: 10.1007/s10863-021-09927-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Jia S, Chai L, Zhang J, Zhang M, Li L, Qi Y, Pang Y, Chen X, Fan N, Wang L, Wang Y, Song J, Sun Y, Wang Y, Miao L, Zhang H. Wei Chang An pill regulates gastrointestinal motility in a bidirectional manner. Pharm Biol 2021;59:1452-63. [PMID: 34711130 DOI: 10.1080/13880209.2021.1991383] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Jiang Y, Castro J, Blomster LV, Agwa AJ, Maddern J, Schober G, Herzig V, Chow CY, Cardoso FC, Demétrio De Souza França P, Gonzales J, Schroeder CI, Esche S, Reiner T, Brierley SM, King GF. Pharmacological Inhibition of the Voltage-Gated Sodium Channel NaV1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome. ACS Pharmacol Transl Sci 2021;4:1362-78. [PMID: 34423271 DOI: 10.1021/acsptsci.1c00072] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Shi X, Hu Y, Zhang B, Li W, Chen JD, Liu F. Ameliorating effects and mechanisms of transcutaneous auricular vagal nerve stimulation on abdominal pain and constipation. JCI Insight 2021;6:150052. [PMID: 34138761 DOI: 10.1172/jci.insight.150052] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Welander NZ, Olivo G, Pisanu C, Rukh G, Schiöth HB, Mwinyi J. Migraine and gastrointestinal disorders in middle and old age: A UK Biobank study. Brain Behav 2021. [PMID: 34291601 DOI: 10.1002/brb3.2291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Beinvogl BC, Manini ML, Camilleri M, Donato LJ, Harmsen WS, Absah I, Burch E, Schechter NL, Nurko S. Markers of Bile Acid Metabolism in Pediatric Diarrhea Predominant Irritable Bowel Syndrome and Healthy Controls. J Pediatr Gastroenterol Nutr 2021;72:859-65. [PMID: 33976086 DOI: 10.1097/MPG.0000000000003067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lackner JM, Quigley BM, Radziwon CD, Vargovich AM. IBS Patients' Treatment Expectancy and Motivation Impacts Quality of the Therapeutic Alliance With Provider: Results of the IBS Outcome Study. J Clin Gastroenterol 2021;55:411-21. [PMID: 32301832 DOI: 10.1097/MCG.0000000000001343] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Yang H, Chen H, Hu B. Evaluation of the short-term efficacy of local analgesic (lidocaine) and opioid analgesic (sufentanil) on patients with centrally mediated abdominal pain syndrome: a randomized controlled trial. Therap Adv Gastroenterol 2021;14:17562848211021783. [PMID: 34249145 DOI: 10.1177/17562848211021783] [Reference Citation Analysis]
16 Simon E, Călinoiu LF, Mitrea L, Vodnar DC. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome. Nutrients 2021;13:2112. [PMID: 34203002 DOI: 10.3390/nu13062112] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
17 Shrivastava A, Mittal A. A Mini Review on Characteristics and Analytical Methods of Otilonium Bromide. Crit Rev Anal Chem 2021;:1-9. [PMID: 34039224 DOI: 10.1080/10408347.2021.1913983] [Reference Citation Analysis]
18 Barbuti RC, Schiavon LL, Oliveira CP, Alvares-DA-Silva MR, Sassaki LY, Passos MDCF, Farias AQ, Barros LL, Barreto BP, Albuquerque GBML, Alves AM, Navarro-Rodriguez T, Bittencourt PL. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG). Arq Gastroenterol 2020;57:381-98. [PMID: 33331485 DOI: 10.1590/S0004-2803.202000000-72] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
19 Khalilian A, Ahmadimoghaddam D, Saki S, Mohammadi Y, Mehrpooya M. A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome. Biopsychosoc Med 2021;15:3. [PMID: 33536043 DOI: 10.1186/s13030-021-00205-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
20 Yao CJ, Li YL, Pu MJ, Luo LH, Feng PM. Traditional Chinese medicine for irritable bowel syndrome: A protocol for meta-analysis. Medicine (Baltimore) 2020;99:e23394. [PMID: 33235116 DOI: 10.1097/MD.0000000000023394] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Månsson S, Ekberg O, Ohlsson B. Motility index measured by magnetic resonance enterography is associated with sex and mural thickness. World J Gastroenterol 2020; 26(36): 5484-5497 [PMID: 33024399 DOI: 10.3748/wjg.v26.i36.5484] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Guerreiro M, Sousa Guerreiro C, Cravo M. Irritable bowel syndrome: how can symptoms and quality of life be improved with diet? Curr Opin Clin Nutr Metab Care 2019;22:377-82. [PMID: 31313689 DOI: 10.1097/MCO.0000000000000589] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Vahora IS, Tsouklidis N, Kumar R, Soni R, Khan S. How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel Syndrome. Cureus 2020;12:e9871. [PMID: 32968548 DOI: 10.7759/cureus.9871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
24 Stemboroski L, Schey R. Treating Chronic Abdominal Pain in Patients with Chronic Abdominal Pain and/or Irritable Bowel Syndrome. Gastroenterol Clin North Am 2020;49:607-21. [PMID: 32718573 DOI: 10.1016/j.gtc.2020.05.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Madisch A, Labenz C, Hollenz M, Gross M, Labenz J. [Therapeutic management of irritable bowel syndrome in the family doctor's practice - probiotics and phytotherapeutics are often used successfully]. MMW Fortschr Med 2020;162:7-13. [PMID: 32661893 DOI: 10.1007/s15006-020-0658-6] [Reference Citation Analysis]
26 Bai T, Zeng H, Long Y, Li X, Sun X, Lan Y, Gao L, Zhang L, Feng Z, Hou X. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial. Trials 2020;21:597. [PMID: 32605578 DOI: 10.1186/s13063-020-04490-0] [Reference Citation Analysis]
27 Tsai Y, Tsai W, Qing Z, Chang C. Dichotomous effects of microbial membrane vesicles on the regulation of immunity. Medicine in Microecology 2020;3:100009. [DOI: 10.1016/j.medmic.2020.100009] [Reference Citation Analysis]
28 D'Silva A, MacQueen G, Nasser Y, Taylor LM, Vallance JK, Raman M. Yoga as a Therapy for Irritable Bowel Syndrome. Dig Dis Sci 2020;65:2503-14. [PMID: 31832970 DOI: 10.1007/s10620-019-05989-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
29 Ohlsson B, Dahlin LB, Englund E, Veress B. Autonomic and peripheral neuropathy with reduced intraepidermal nerve fiber density can be observed in patients with gastrointestinal dysmotility. Clin Case Rep. 2020;8:142-148. [PMID: 31998505 DOI: 10.1002/ccr3.2575] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
30 Lindberg G. Pseudo-obstruction, enteric dysmotility and irritable bowel syndrome. Best Pract Res Clin Gastroenterol. 2019;40-41:101635. [PMID: 31594655 DOI: 10.1016/j.bpg.2019.101635] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Trifan A, Burta O, Tiuca N, Petrisor DC, Lenghel A, Santos J. Efficacy and safety of Gelsectan for diarrhoea-predominant irritable bowel syndrome: A randomised, crossover clinical trial. United European Gastroenterol J 2019;7:1093-101. [PMID: 31662866 DOI: 10.1177/2050640619862721] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
32 Molina-Tijeras JA, Gálvez J, Rodríguez-Cabezas ME. The Immunomodulatory Properties of Extracellular Vesicles Derived from Probiotics: A Novel Approach for the Management of Gastrointestinal Diseases. Nutrients 2019;11:E1038. [PMID: 31075872 DOI: 10.3390/nu11051038] [Cited by in Crossref: 26] [Cited by in F6Publishing: 37] [Article Influence: 8.7] [Reference Citation Analysis]
33 Shi SM, Wen YL, Hou HB, Liu HX. Effectiveness of vitamin D for irritable bowel syndrome: A protocol for a systematic review of randomized controlled trial. Medicine (Baltimore) 2019;98:e14723. [PMID: 30817618 DOI: 10.1097/MD.0000000000014723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
34 Rexwinkel R, Zeevenhooven J, van Etten-Jamaludin FS, Benninga MA, Tabbers MM. Side effects associated with pharmacotherapy for pediatric irritable bowel syndrome and functional abdominal pain - not otherwise specified: a systematic review. Expert Opin Drug Saf 2019;18:111-25. [PMID: 30676113 DOI: 10.1080/14740338.2019.1574295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
35 Alharbi SH, Alateeq FA, Alshammari KI, Alshammri ASS, Alabdali NAN, Alsulaiman MAS, Algothi SMI, Altoraifi AS, Almutairi MQ, Ahmed HG. Irritable Bowel Syndrome and Dietary Habits in Northern Saudi Arabia. Health 2019;11:289-97. [DOI: 10.4236/health.2019.113025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]